Australia - English - Department of Health (Therapeutic Goods Administration)

mindray ultrasound - 40761 - ultrasound system, imaging, general-purpose - a range of general-purpose diagnostic ultrasound imaging systems designed exclusively for use in a wide variety of both extracorporeal and/or intracorporeal body imaging procedures. these ultrasound systems support a wide variety of transducers and related software allowing for the collection, display and analysis of ultrasound information. usages are, e.g. general-purpose imaging, cardiac, ob/gyn, endoscopy, breast, prostate, vascular, intra-surgical, doppler or colour doppler. selection of a transducer and associated software enables these different types of examinations.

United States - English - NLM (National Library of Medicine)

ranbaxy laboratories inc. - halobetasol propionate (unii: 91a0k1ty3z) (halobetasol - unii:9p6159hm7t) - halobetasol propionate 0.5 mg in 1 g - ultravate cream 0.05% is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. treatment beyond two consecutive weeks is not recommended, and the total dosage should not exceed 50 g/week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (hpa) axis. use in children under 12 years of age is not recommended. as with other highly active corticosteroids, therapy should be discontinued when control has been achieved. if no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. ultravate cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - halobetasol propionate (unii: 91a0k1ty3z) (halobetasol - unii:9p6159hm7t) - halobetasol propionate 0.5 mg in 1 g - ultravate lotion is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. none. risk summary there are no available data on ultravate lotion use in pregnant women to inform a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. published data report an increased risk of low birthweight with the use of greater than 300 grams of potent or very potent topical corticosteroid during pregnancy. in animal reproduction studies, halobetasol propionate administered systemically during organogenesis to pregnant rats at 13 and 33 times the human topical dose and to pregnant rabbits at 3 times the human topical dose resulted in teratogenic and embryotoxic effects [see data]. the clinical relevance of the animal findings is not clear. the background risk of major birth defects and miscarriage for the indicated population are unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in cli

United States - English - NLM (National Library of Medicine)

ranbaxy laboratories inc. - halobetasol propionate (unii: 91a0k1ty3z) (halobetasol - unii:9p6159hm7t) - halobetasol propionate 0.5 mg in 1 g - ultravate is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. treatment beyond two consecutive weeks is not recommended, and the total dosage should not exceed 50 g/week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (hpa) axis. use in children under 12 years of age is not recommended. as with other highly active corticosteroids, therapy should be discontinued when control has been achieved. if no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. ultravate is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

ranbaxy laboratories inc. - halobetasol propionate (unii: 91a0k1ty3z) (halobetasol - unii:9p6159hm7t) - halobetasol propionate 0.50 mg in 1 g - ultravate ointment 0.05% is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. treatment beyond two consecutive weeks is not recommended, and the total dosage should not exceed 50 g/week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (hpa) axis. use in children under 12 years of age is not recommended. as with other highly active corticosteroids, therapy should be discontinued when control has been achieved. if no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. ultravate ointment is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

New Zealand - English - Ministry for Primary Industries

bayer new zealand limited - glyphosate - soluble concentrate - glyphosate 570 g/litre - herbicide - herbicide

United States - English - NLM (National Library of Medicine)

ultra seal corporation - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i) - neomycin sulfate 5 mg in 1 g - purpose: first aid antibiotic  first aid to help prevent infection in minor cuts, burns, scrapes

United States - English - NLM (National Library of Medicine)

ultra seal corporation - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - guaifenesin 100 mg in 5 ml - purpose: expectorant, antitussive (anti cough) uses: temporarily: • helps loosen phlegm (mucus) • thin bronchial secretions to drain bronchial tubes, and make coughs more productive. •    restores free breathing •    suppresses cough due to minor throat and bronchial irritation associated with a cold or inhaled irritants

United States - English - NLM (National Library of Medicine)

ultra seal corporation - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i) - bacitracin 500 [iu] in 1 g - purpose: first aid antibiotic  first aid to help prevent infection in minor cuts, burns, scrapes

United States - English - NLM (National Library of Medicine)

ultra v co., ltd - dimethicone (unii: 92ru3n3y1o) (dimethicone - unii:92ru3n3y1o) - dimethicone 3.81 g in 50 ml - purpose: skin protectant uses: helps protect skin